REFRACTORY MELANOMA
Clinical trials for REFRACTORY MELANOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MELANOMA trials appear
Sign up with your email to follow new studies for REFRACTORY MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial hopes to tame tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like certain melanomas, ovarian, and uterine cancers). The main goal is to find the safest dose and understand side effects. About 54 adults will t…
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Engineered immune cells take on hard-to-treat melanoma in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment made from a person's own immune cells (NK cells) that are engineered to recognize and attack melanoma cells carrying a protein called PRAME. The study enrolls adults with advanced melanoma that has not responded to standard immunothera…
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New immune therapy targets Hard-to-Treat melanoma
Disease control Recruiting nowThis study tests a new treatment called DOC1021 for people with advanced melanoma that has not responded to standard therapies. The treatment uses a patient's own immune cells, trained to attack their specific tumor, along with an immune-boosting injection. The goal is to see if …
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Diakonos Oncology Corporation • Aim: Disease control
Last updated May 07, 2026 18:43 UTC